Friday, 06 Dec 2019

You are here

Gout and the Social Determinants of Health

Sir Michael Marmot is one of my medical heroes. Despite appearing to be the epitome of British establishment medicine, in fact he was raised in Australia and received his medical degree from the University of Sydney, so we like to claim him as one our own.

He is best known for his work as a pioneer in the field of the social determinants of health. This began with his seminal work on the Whitehall study, which tracked mortality among public servants in the UK and, to everyone’s surprise, did not find an excess of cardiovascular deaths among the highly stressed upper strata of the workplace hierarchy, but instead showed a robust inverse linear association between mortality and position in the social hierarchy. The higher you are in the social structure, the less likely you are to suffer from chronic disease and premature death. Importantly, this association was found in a relatively affluent population, where material deprivation was not a concern, and suggests that social factors are fundamental upstream drivers of a variety of health-related behaviours and experiences that are primarily responsible for the distribution of chronic disease within society - or what Marmot has termed the “causes of the causes”. Such as association has since been confirmed in a variety of different social contexts and for a wide range of chronic disease states. Striving to achieve good health, then, is the province not just of the individual, but also of society and the policy-makers who influence its structure.

“The stark fact is that most disease on the planet is attributable to the social conditions in which people live and work.”
Stonington & Holmes, PLoS Medicine 3(10):1661(2006)

During a fascinating gout session on October 21, Hyon Choi presented an important paper (abstract 874) which used data from the Health Professionals Follow-up Study to try to understand the rapid increase in the incidence of gout in recent decades. Data from over 44,000 men in the HPFS demonstrated that five factors (BMI, diet, diuretic use, alcohol consumption, and vitamin C supplementation) accounted for 80% of the population attributable risk of incident gout. In other words, if we could eliminate poor diet, obesity, and alcohol use, we could largely prevent incident gout. Clearly this is a goal best addressed at the social level rather than the individual level - it is not so much the individual’s decisions about diet and alcohol that is important in the population, but much more the structures that influence these decisions: the “causes of the causes”. Gout is not just a highly-treatable disease, it is potentially highly-preventable. For me, this paper is a call to action both for rheumatologists and for our politicians and policy-makers. Or, in the prescient words of the great Rudolf Virchow:

“Medicine is a social science and politics is nothing else but medicine on a large scale. Medicine as a social science, as the science of human beings, has the obligation to point out problems and to attempt their theoretical solution; the politician, the practical anthropologist, must find the means for their actual solution”

Add new comment

More Like This

Pegradicase+ImmTOR SEL-212 Shows Promising Results In Active Gout

Therapies targeting sUA accumulation or improving its excretion are widely used for treatment of symptoms and prevention of progression of gout for decades. Despite our best effort, there is still a significant amount of patients who remain symptomatic and/or experiences progressive joint damage and disability. Regardless of the cause, either its lack of compliance or poor tolerability, more effective treatments are needed.

PANLAR Ultrasound Study Group: Recommendations On Imaging Modalities In Gout

Gout is a systemic inflammatory disease with high potential for joint damage due to erosive changes and MSU deposits resulting in disability and chronic pain. Prompt diagnosis and effective treatment are key to better long term outcomes and decreased disability.

T2T Lowers Mortality in Gout

A Spanish prospective cohort of active, uncontrolled gout patients were followed and showed that failure to reach a target serum uric acid (sUA) level of 6 mg/dl (0.36 mmol/L) or less was associated with a 2-3 fold increase in mortality.

Novel Inhibition of MSU Crystal Inflammation

Researchers from Washington State University have shown that inhibition of tumor growth factor-β (TGF-β)-activated kinase 1 (TAK1) can effectively downregulate inflammatory mediators and suppress inflammation caused by gout.

Monosodium urate (MSU) crystals directly activate the inflammasome to produce a plethora of pro-inflammatory cytokines, including interleukin-1β (IL-1β). 

Patients Prefer Nurse Led Care for their Gout

Despite the well known, well publicized treat-to-target (T2T) goal of a serum uric acid (SUA) level < 6 mg/dl, this goal is seldom achieved (< 40%) in clinical practice and patient adherence has been unacceptably low. A recent study shows that nurse-led care led to better outcomes in gout including patient acceptability, long-term adherence, and less flares.